These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37686417)

  • 1. Can Nitric Oxide-Based Therapy Be Improved for the Treatment of Cancers? A Perspective.
    Sinha BK
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells.
    Sinha BK; Perera L; Cannon RE
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.
    Sinha BK; Perera L; Cannon RE
    Biomed Pharmacother; 2019 Dec; 120():109468. PubMed ID: 31605952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.
    Ren Z; Gu X; Lu B; Chen Y; Chen G; Feng J; Lin J; Zhang Y; Peng H
    J Cell Mol Med; 2016 Jun; 20(6):1095-105. PubMed ID: 26864945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than skin deep: using polymers to facilitate topical delivery of nitric oxide.
    Oliver S; Pham TTP; Li Y; Xu FJ; Boyer C
    Biomater Sci; 2021 Jan; 9(2):391-405. PubMed ID: 32856653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS; He W; Yin L
    Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer.
    Chen M; Song F; Liu Y; Tian J; Liu C; Li R; Zhang Q
    Nanoscale; 2019 Mar; 11(9):3814-3826. PubMed ID: 30600823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
    Seabra AB; Durán N
    Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitizing activities of nitric oxide donors for cancer resistance to anticancer therapeutic drugs.
    Bonavida B
    Biochem Pharmacol; 2020 Jun; 176():113913. PubMed ID: 32173364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
    Yu M; Ocana A; Tannock IF
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines.
    Cuestas ML; Sosnik A; Mathet VL
    Mol Pharm; 2011 Aug; 8(4):1152-64. PubMed ID: 21591727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ABC transporters in clinical practice.
    Leonard GD; Fojo T; Bates SE
    Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
    Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based carriers for controlled delivery of nitric oxide.
    Elnaggar MA; Subbiah R; Han DK; Joung YK
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1341-1353. PubMed ID: 28117595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications for nitric oxide in halting proliferation of tumor cells.
    Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
    Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric Nitric Oxide Delivery Nanoplatforms for Treating Cancer, Cardiovascular Diseases, and Infection.
    Jin G; Gao Z; Liu Y; Zhao J; Ou H; Xu F; Ding D
    Adv Healthc Mater; 2021 Feb; 10(3):e2001550. PubMed ID: 33314793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.